Dianthus Therapeutics (DNTH) PT Raised to $132 at Jefferies
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Price: $105.60 +2.76%
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 22
Rating Summary:
15 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 20 | New: 22
Join SI Premium – FREE
Jefferies analyst Maury Raycroft raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $132.00 (from $110.00) while maintaining a Buy rating.
You May Also Be Interested In
- Cantor Fitzgerald Downgrades DOMO (DOMO) to Neutral
- Crown Castle (CCI) PT Lowered to $96 at Bernstein SocGen Group
- CSX (CSX) PT Raised to $48 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
